Anlon Healthcare Revises Acquisition Percentages for AOPL and BLPL

Anlon Healthcare Ltd has issued a revised intimation regarding its earlier disclosure on August 08, 2026. The company clarified that the percentage of acquisition in Apiqo Organics Private Limited (AOPL) was inadvertently stated as 32.52% instead of the correct 44.94%. Similarly, the acquisition percentage in Bizotic Lifescience Private Limited (BLPL) was revised from 43.33% to the correct 47.41%. The company regrets the error and confirms all other details from the previous intimation remain unchanged. The acquisition of AOPL is a related party transaction, undertaken on an arm's length basis, aimed at strengthening supply chains and enhancing shareholder value.